This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Decide which cash back credit card you should get by assessing your spending habits. Find the best rewards for you.
27,595 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
A memory themed ETF is drawing intense inflows, triggering questions about momentum versus risk. This guide breaks do...
A high-profile former AI czar challenges Sanders’ 50% government stake plan for AI firms, warning that nationalizatio...
Astera Labs stock skyrocketed last month as multiple catalysts converged. This deep-dive breaks down the driving forc...
When a local emergency provider faces a court case over funds, it isn’t just a headline—it can affect budgets, bills,...
XRP remains under scrutiny as 2026 unfolds, with faster settlement times and evolving regulation shaping its appeal. ...
A veteran on-chain analyst says bitcoin entering phase bear as volatility climbs and liquidity tightens, signaling a ...
Tech giants Google and TESLA join a broad coalition to reduce U.S. electricity costs by tapping underused grid capaci...
A lithium-focused startup has joined the unicorn club after a surge in demand for EV batteries. The move signals a br...
Ripple’s latest briefing argues passive Zcash holders remain protected if they did not trigger the exploit, even as m...
NVIDIA delivered a blockbuster quarter while Cerebras reported explosive inference speed that still risks negative ma...